As hospital leaders prepared to meet with their lawmakers on April 16 following the conclusion of the AHA's 2024 Annual Membership Meeting, Sen. Dick Durbin, D-Ill., urged hospitals to speak up about the challenges and realities they face, particularly as they contend with crippling workforce shortages nationwide.

“People don't want to hear a speech, they love to hear a story — and you’ve got plenty of them,” Durbin said. “So, when it comes to the financial situations you’re facing, when it comes to medical professionals’ challenges, tell [lawmakers] the story.”
 
Durbin is a primary driver behind several pieces of AHA-supported legislation. The bipartisan, Durbin-sponsored Healthcare Workforce Resilience Act would recapture up to 40,000 unused employment visas for nurses and for physicians. A separate bill sponsored by Durbin, the bipartisan Restoring America’s Health Care Workforce and Readiness Act, would reauthorize the mandatory portion of the National Health Service Corps through fiscal year 2026 and double funding for its scholarships and loan repayment for health care workers who serve in federally designated shortage areas.
 

Headline
The AHA Aug. 28 shared concerns with the Centers for Medicare & Medicaid Services regarding the calendar year 2027 hospital outpatient prospective payment…
Headline
The AHA provided comments to the Centers for Medicare & Medicaid Services Aug. 28 on its calendar year 2027 home health prospective payment system proposed…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
The AHA’s Association for the Health Care Environment will host a webinar Sept. 8 at 2 p.m. ET that will discuss strategies environmental services leaders can…
Headline
The Department of Homeland Security today released a proposed rule to establish a new $103,265 filing fee for H-1B visa petitions that are subject to statutory…
Headline
President Trump announced Aug. 19 that he has nominated Heidi Overton to serve as the next commissioner of the Food and Drug Administration. Overton currently…